Spero Therapeutics Other Stockholder Equity Over Time
| SPRO Stock | USD 1.33 0.01 0.76% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Spero Therapeutics Performance and Spero Therapeutics Correlation. Spero |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Spero Therapeutics. If investors know Spero will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Spero Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.753 | Earnings Share 0.34 | Revenue Per Share 2.223 | Quarterly Revenue Growth 2.754 | Return On Assets 0.1048 |
The market value of Spero Therapeutics is measured differently than its book value, which is the value of Spero that is recorded on the company's balance sheet. Investors also form their own opinion of Spero Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Spero Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Spero Therapeutics' market value can be influenced by many factors that don't directly affect Spero Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Spero Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Spero Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Spero Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Other Stockholder Equity Analysis
Compare Spero Therapeutics and related stocks such as Assembly Biosciences, Achilles Therapeutics PLC, and Instil Bio Other Stockholder Equity Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASMB | 3.9 M | 102.1 M | 110.1 M | 136.2 M | 194.1 M | 283.5 M | 288.7 M | 364.5 M | 552.8 M | 712.8 M | 742.4 M | 800.7 M | 807.9 M | 826.9 M | 868.3 M |
| ACHL | (395 K) | (395 K) | (395 K) | (395 K) | (395 K) | (395 K) | (395 K) | (395 K) | (395 K) | 118 M | 234.9 M | 401.9 M | 409 M | 415.2 M | 289.4 M |
| TIL | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (14.7 M) | (326.4 M) | 147 M | 789 M | 807.2 M | 847.5 M |
| CTMX | (44.9 M) | (44.9 M) | (44.9 M) | (44.9 M) | (76.9 M) | 46.4 M | 55.7 M | (108.2 M) | (11.2 M) | 468.3 M | 500 M | 623.3 M | 637.1 M | 675.9 M | 709.7 M |
| NXTC | 867 K | 867 K | 867 K | 867 K | 867 K | 867 K | 867 K | 867 K | 2.8 M | 46.4 M | 410.6 M | 421 M | 430.8 M | 439.1 M | 275.2 M |
| NUVB | 421 | 421 | 421 | 421 | 421 | 421 | 421 | 421 | 421 | 421 | 6.5 M | (745.3 M) | (5.5 M) | (5 M) | (5.2 M) |
Spero Therapeutics and related stocks such as Assembly Biosciences, Achilles Therapeutics PLC, and Instil Bio Other Stockholder Equity description
My Equities
My Current Equities and Potential Positions
| Spero Therapeutics | SPRO |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Location | Massachusetts; U.S.A |
| Exchange | NASDAQ Exchange |
USD 1.33
Check out Spero Therapeutics Performance and Spero Therapeutics Correlation. To learn how to invest in Spero Stock, please use our How to Invest in Spero Therapeutics guide.You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Spero Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.